Kidney Disease
Explainable machine learning can improve efforts to diagnose CKD early
Use of explainable machine learning combined with an AI classifier can aid health care providers in making accurate diagnoses and identifying root causes of chronic kidney disease at early stages, research data show.
Baxter agrees to sell kidney care business for $3.8 billion to investment firm Carlyle
Baxter International has agreed to sell its kidney care business to investment group Carlyle for $3.8 billion, according to a press release.
Consuming fruits, vegetables may benefit hypertension treatment, reduce CKD progression
Fruits and vegetables may be beneficial in the treatment of hypertension to reduce chronic kidney disease progression, according to published data.
Preeclampsia during pregnancy can accelerate CKD
Patients with chronic kidney disease who have preeclampsia during pregnancy may face higher risk for long-term kidney function decline or end-stage kidney disease, data show.
National Kidney Foundation releases recommendations for use of genetics in nephrology
The National Kidney Foundation has released new recommendations for the use of genomics to test for, and diagnose, genetic kidney diseases, according to a press release.
Diality receives FDA 510(k) clearance for Moda-flx hemodialysis system
Diality has received FDA 510(k) clearance for its Moda-flx Hemodialysis System for acute and/or chronic renal failure, according to a press release.
NKF hires former CMS staffer to handle government relations
The National Kidney Foundation has named Jesse Roach, MD, who previously worked for CMS and CVS Kidney Care, as senior vice president of government relations, according to a press release.
Cardiovascular, thromboembolic events more closely tied to kidney vs. glomerular disease
Incident cardiovascular and thromboembolic events may be more closely linked to the severity of kidney disease than with glomerular disease subtype, according to results of a prospective study.
Slowing diabetic kidney disease progression may cut health costs for veterans
Slowing the progression to advanced diabetic kidney disease could lower the economic impact of the condition and help health care systems optimize resources, recently published data show.
Ardelyx sues CMS about plan to place phosphate binders into ESRD payment bundle
Ardelyx Inc. is leading a lawsuit against CMS about plans by the agency to include oral-only phosphate-lowering therapies into the End-Stage Renal Disease Prospective Payment System by January 2025.